Pal SK - Search Results

1

Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma.

Pal SK, Hsu J, Hsu S, Hu J, Bergerot P, Carmichael C, Saikia J, Liu X, Lau C, Twardowski P, Figlin RA, Yuh BF. Pal SK, et al. J Geriatr Oncol. 2013 Apr;4(2):128-33. doi: 10.1016/j.jgo.2012.11.001. J Geriatr Oncol. 2013. PMID: 23646100 Free PMC article.

2

The role of targeting mammalian target of rapamycin in lung cancer.

Pal SK, Figlin RA, Reckamp KL. Pal SK, et al. Clin Lung Cancer. 2008 Nov;9(6):340-5. doi: 10.3816/CLC.2008.n.049. Clin Lung Cancer. 2008. PMID: 19073516 Review.

3

Beyond castration and chemotherapy: novel approaches to targeting androgen-driven pathways.

Pal SK, Twardowski P, Josephson DY. Pal SK, et al. Maturitas. 2009 Oct 20;64(2):61-6. doi: 10.1016/j.maturitas.2009.08.004. Epub 2009 Sep 5. Maturitas. 2009. PMID: 19733987 Review.

4

Renal cell carcinoma therapy in 2010: many options with little comparative data.

Pal SK, Figlin RA. Pal SK, et al. Clin Adv Hematol Oncol. 2010 Mar;8(3):191-200. Clin Adv Hematol Oncol. 2010. PMID: 20400934 Review.

5

STAT3: a target to enhance antitumor immune response.

Lee H, Pal SK, Reckamp K, Figlin RA, Yu H. Lee H, et al. Among authors: pal sk. Curr Top Microbiol Immunol. 2011;344:41-59. doi: 10.1007/82_2010_51. Curr Top Microbiol Immunol. 2011. PMID: 20517723 Free PMC article. Review.

6

Targeted therapies for non-small cell lung cancer: an evolving landscape.

Pal SK, Figlin RA, Reckamp K. Pal SK, et al. Mol Cancer Ther. 2010 Jul;9(7):1931-44. doi: 10.1158/1535-7163.MCT-10-0239. Epub 2010 Jun 22. Mol Cancer Ther. 2010. PMID: 20571071 Free PMC article. Review.

7

Targeted therapies: Pazopanib: carving a niche in a crowded therapeutic landscape.

Pal SK, Figlin RA. Pal SK, et al. Nat Rev Clin Oncol. 2010 Jul;7(7):362-3. doi: 10.1038/nrclinonc.2010.83. Nat Rev Clin Oncol. 2010. PMID: 20592710 No abstract available.

8

Targeted therapies for renal cell carcinoma: understanding their impact on survival.

Pal SK, Figlin RA. Pal SK, et al. Target Oncol. 2010 Jun;5(2):131-8. doi: 10.1007/s11523-010-0145-6. Epub 2010 Jul 15. Target Oncol. 2010. PMID: 20632214 Review.

9

Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors.

Pal SK, Figlin RA. Pal SK, et al. Clin Med Insights Oncol. 2010 Jun 9;4:43-53. doi: 10.4137/cmo.s1590. Clin Med Insights Oncol. 2010. PMID: 20711245 Free PMC article.

10

Deciphering the anticancer mechanisms of sunitinib.

Pal SK, Figlin RA, Yu H. Pal SK, et al. Cancer Biol Ther. 2010 Oct 1;10(7):712-4. doi: 10.4161/cbt.10.7.13130. Epub 2010 Oct 1. Cancer Biol Ther. 2010. PMID: 20716960 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,149 results

Search Page

Filters